Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 2Phase 3 1

Status

Unknown 3Completed 2Recruiting 1

Sponsor Class

OTHER 436INDUSTRY 226NIH 66NETWORK 9OTHER_GOV 6

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 3Dermatologic 3Sarcoma 1

Conditions

Uveal Melanoma 2Sarcoma 1Pancreatic Neoplasms 1Osteosarcoma 1Melanoma 1Gastrointestinal Stromal Tumors 1Diabetes Mellitus, Insulin-Dependent, 12 1Desmoplastic Small Round Cell Tumor 1Colonic Neoplasms 1Chondrosarcoma 1Bone Neoplasms 1

Interventions

Cisplatin 49Capecitabine 41apatinib 34Gemcitabine 33Oxaliplatin 32Cyclophosphamide 31Radiotherapy 29Paclitaxel 29Carboplatin 29tislelizumab 27Irinotecan 27Drug Therapy 27Fluorouracil 26Docetaxel 26Bevacizumab 23fludarabine 18Surgical Procedures, Operative 17Nivolumab 17pembrolizumab 16Exercise 16Metformin 15camrelizumab 14S 1 (combination) 14Radiation 14Pemetrexed 13Control Groups 12anlotinib 11Leucovorin 11toripalimab 10Vinorelbine 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
OTHER_GOV × Interventional × Ipilimumab × Clear all
NCT04463368 2025-03-28

SCANDIUM II

Vastra Gotaland Region

Phase 1 Completed
18 enrolled
Dermatologic

Uveal Melanoma

NCT06519266 2024-11-25

SCANDIUM-III

Vastra Gotaland Region

Phase 3 Recruiting
40 enrolled
Dermatologic

Uveal Melanoma

NCT05088889 2023-11-28

Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer

Sheba Medical Center

Phase 1 Unknown
10 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT03507699 2023-04-18

Combined Immunotherapy and Radiosurgery for Metastatic Colorectal Cancer

Sheba Medical Center

Phase 1 Completed
19 enrolled
Gastrointestinal

Diabetes Mellitus, Insulin-Dependent, 12, Colonic Neoplasms

NCT03166397 2023-01-26

Adoptive Cell Therapy Following a Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Melanoma Patients

Sheba Medical Center

Phase 2 Unknown
30 enrolled
Dermatologic

Melanoma

NCT02982486 2017-11-01

A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma

Assaf-Harofeh Medical Center

Phase 2 Unknown
60 enrolled
GastrointestinalSarcoma

Bone Neoplasms, Chondrosarcoma, Sarcoma, Osteosarcoma, Gastrointestinal Stromal Tumors, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡